Table of Contents

2019-2024 Global Nootropics Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Nootropics Consumption 2014-2024
  • 2.1.2 Nootropics Consumption CAGR by Region
• 2.2 Nootropics Segment by Type
  • 2.2.1 Attention and Focus
  • 2.2.2 Memory Enhancement
  • 2.2.3 Mood and Depression
  • 2.2.4 Sleep and Anxiety
  • 2.2.5 Others
• 2.3 Nootropics Consumption by Type
  • 2.3.1 Global Nootropics Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Nootropics Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Nootropics Sale Price by Type (2014-2019)
• 2.4 Nootropics Segment by Application
  • 2.4.1 Adult
  • 2.4.2 Kid
• 2.5 Nootropics Consumption by Application
  • 2.5.1 Global Nootropics Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Nootropics Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Nootropics Sale Price by Application (2014-2019)

3 Global Nootropics by Players

• 3.1 Global Nootropics Sales Market Share by Players
  • 3.1.1 Global Nootropics Sales by Players (2017-2019)
  • 3.1.2 Global Nootropics Sales Market Share by Players (2017-2019)
• 3.2 Global Nootropics Revenue Market Share by Players
  • 3.2.1 Global Nootropics Revenue by Players (2017-2019)
  • 3.2.2 Global Nootropics Revenue Market Share by Players (2017-2019)
• 3.3 Global Nootropics Sale Price by Players
• 3.4 Global Nootropics Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Nootropics Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Nootropics Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Nootropics by Regions

• 4.1 Nootropics by Regions
  • 4.1.1 Global Nootropics Consumption by Regions
  • 4.1.2 Global Nootropics Value by Regions
• 4.2 Americas Nootropics Consumption Growth
• 4.3 APAC Nootropics Consumption Growth
• 4.4 Europe Nootropics Consumption Growth
• 4.5 Middle East & Africa Nootropics Consumption Growth

5 Americas

• 5.1 Americas Nootropics Consumption by Countries
  • 5.1.1 Americas Nootropics Consumption by Countries (2014-2019)
  • 5.1.2 Americas Nootropics Value by Countries (2014-2019)
• 5.2 Americas Nootropics Consumption by Type
• 5.3 Americas Nootropics Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Nootropics Consumption by Countries
  • 6.1.1 APAC Nootropics Consumption by Countries (2014-2019)
  • 6.1.2 APAC Nootropics Value by Countries (2014-2019)
• 6.2 APAC Nootropics Consumption by Type
• 6.3 APAC Nootropics Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Nootropics by Countries
  • 7.1.1 Europe Nootropics Consumption by Countries (2014-2019)
  • 7.1.2 Europe Nootropics Value by Countries (2014-2019)
• 7.2 Europe Nootropics Consumption by Type
• 7.3 Europe Nootropics Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Nootropics by Countries
  • 8.1.1 Middle East & Africa Nootropics Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Nootropics Value by Countries (2014-2019)
• 8.2 Middle East & Africa Nootropics Consumption by Type
• 8.3 Middle East & Africa Nootropics Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Nootropics Distributors
• 10.3 Nootropics Customer

11 Global Nootropics Market Forecast

• 11.1 Global Nootropics Consumption Forecast (2019-2024)
• 11.2 Global Nootropics Forecast by Regions
  • 11.2.1 Global Nootropics Forecast by Regions (2019-2024)
  • 11.2.2 Global Nootropics Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Nootropics Forecast by Type
• 11.8 Global Nootropics Forecast by Application

12 Key Players Analysis

• 12.1 Nootrobox
  • 12.1.1 Company Details
  • 12.1.2 Nootropics Product Offered
  • 12.1.3 Nootrobox Nootropics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Nootrobox News
• 12.2 Cephalon
  • 12.2.1 Company Details
  • 12.2.2 Nootropics Product Offered
  • 12.2.3 Cephalon Nootropics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Cephalon News
• 12.3 Purelife Bioscience
  • 12.3.1 Company Details
  • 12.3.2 Nootropics Product Offered
  • 12.3.3 Purelife Bioscience Nootropics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Purelife Bioscience News
• 12.4 Peak Nootropics
  • 12.4.1 Company Details
  • 12.4.2 Nootropics Product Offered
  • 12.4.3 Peak Nootropics Nootropics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Peak Nootropics News
• 12.5 Nootrico
  • 12.5.1 Company Details
  • 12.5.2 Nootropics Product Offered
  • 12.5.3 Nootrico Nootropics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Nootrico News
• 12.6 SupNootropic Biological Technology
  • 12.6.1 Company Details
  • 12.6.2 Nootropics Product Offered
  • 12.6.3 SupNootropic Biological Technology Nootropics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 SupNootropic Biological Technology News
• 12.7 AlternaScript
  • 12.7.1 Company Details
  • 12.7.2 Nootropics Product Offered
  • 12.7.3 AlternaScript Nootropics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 AlternaScript News
• 12.8 Accelerated Intelligence
  • 12.8.1 Company Details
  • 12.8.2 Nootropics Product Offered
  • 12.8.3 Accelerated Intelligence Nootropics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 Accelerated Intelligence News
• 12.9 Onnit Labs
  • 12.9.1 Company Details
  • 12.9.2 Nootropics Product Offered
  • 12.9.3 Onnit Labs Nootropics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 Onnit Labs News
• 12.10 Powder City
  • 12.10.1 Company Details
  • 12.10.2 Nootropics Product Offered
  • 12.10.3 Powder City Nootropics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.10.4 Main Business Overview
  • 12.10.5 Powder City News
• 12.11 Ceretropic
• 12.12 Nootropic Source
• 12.13 Clarity Nootropics

13 Research Findings and Conclusion

Nootropics are medicines and natural derivatives that enhance cognitive functions including memory, motivation, and creativity in healthy persons. Nootropics have been accessible across the globe for many years and were constituted of ingredients such as multivitamins and caffeine – the products approved by the FDA as dietary supplements and termed as GRAS (generally regarded as safe).

According to this study, over the next five years the Nootropics market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Nootropics business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Nootropics market by product type, application, key manufacturers and key regions and countries.

This study considers the Nootropics value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Attention and Focus
Memory Enhancement
Mood and Depression
Sleep and Anxiety
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Adult
Kid

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Nootrobox
Cephalon
Purelife Bioscience
Peak Nootropics
Nootrico
SupNootropic Biological Technology
AlternaScript
Accelerated Intelligence
Onnit Labs
Powder City
Ceretropic
Nootropic Source
Clarity Nootropics

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Nootropics consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Nootropics market by identifying its various subsegments.
Focuses on the key global Nootropics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Nootropics with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Nootropics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.